- Report
- January 2026
- 197 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 194 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 194 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 183 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- February 2026
- 194 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1752EUR$2,000USD£1,520GBP
- Drug Pipelines
- April 2025
- 100 Pages
Global
From €1752EUR$2,000USD£1,520GBP
- Report
- January 2026
- 185 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- June 2025
- 400 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- July 2025
- 215 Pages
Global
From €4375EUR$4,995USD£3,797GBP
- Report
- October 2025
- 83 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- July 2025
- 80 Pages
United States
From €5211EUR$5,950USD£4,523GBP
- Report
- April 2023
- 175 Pages
Global
From €5166EUR$5,899USD£4,484GBP
- Report
- January 2024
- 120 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- July 2024
- 150 Pages
Global
From €3284EUR$3,750USD£2,851GBP
- Report
- February 2024
- 111 Pages
Global
From €4160EUR$4,750USD£3,611GBP

Oxazolidinones are a class of antibiotics used to treat a variety of bacterial infections. They are bacteriostatic, meaning they inhibit the growth of bacteria, rather than killing them. Oxazolidinones are generally used to treat infections caused by Gram-positive bacteria, such as Staphylococcus aureus and Streptococcus pneumoniae. They are also used to treat infections caused by some Gram-negative bacteria, such as Pseudomonas aeruginosa. Oxazolidinones are generally well-tolerated and have few side effects.
Oxazolidinones are an important part of the antibiotics market, as they are effective against a wide range of bacterial infections. They are often used as a first-line treatment for infections caused by Gram-positive bacteria, and are increasingly being used to treat infections caused by Gram-negative bacteria.
Some companies in the Oxazolidinones market include Merck & Co., Inc., Pfizer, Inc., and Allergan plc. Show Less Read more